ENANTIOMERICALLY PURE beta -D-DIOXOLANE-NUCLEOSIDES
A method and composition for the treatment of humans infected with HIV that includes the administration of an HIV treatment amount of an enantiomerically pure (beta)-D-dioxolanyl purine nucleoside of formula (I), wherein R is OH, Cl, NH2, or H, or a pharmaceutically acceptable salt or derivative of the compound, optionally in a pharmaceutically acceptable carrier or diluent.
Attached files:Patents:AT 498,624
Inventor(s):
CHU CHUNG K [US]; SCHINAZI RAYMOND F [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents